The Comparative Advantages of Medical Device Investing
This article was originally published in Start Up
Executive Summary
Given the currently dismal valuations of public biotechnology companies and with no near-term expectation of an upturn in investor appetites, venture funds are increasingly interested in medical device investing thanks to their lower capital costs and likely exits via acquisitions.